Company Propanc Biopharma Inc Other OTC
Equities
US74346N1072
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 07-10-14 | |
Julian Kenyon
FOU | Founder | 77 | 07-10-14 |
Klaus Kutz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 07-10-14 | |
Julian Kenyon
FOU | Founder | 77 | 07-10-14 |
Josef Zelinger
BRD | Director/Board Member | 74 | 20-12-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1 | 0 | 0 | 99.78 % |
Stock B | 1 | 331,935,348 | 331,216,641 ( 99.78 %) | 0 |
Company contact information
Propanc Biopharma, Inc.
6 Butler Street Suite 302
3124, Camberwell
+61 3 9882 0780
http://www.propanc.com![address Propanc Biopharma Inc](https://cdn.zonebourse.com/static/address/34610540.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.63% | 127B | |
+25.04% | 27.67B | |
-20.17% | 20.33B | |
-17.08% | 16.79B | |
-18.07% | 15.63B | |
-47.70% | 14.65B | |
+11.92% | 14.84B | |
+58.32% | 14.43B | |
+149.98% | 12.49B |